by Kristi Pollard | Jan 17, 2022 | Covid News, Webinar Q&As
Q: Is code U07.1 always sequenced first when a patient has a COVID-related condition?A: No. Sequencing for code U07.1 follows the circumstances of admission. If the patient was admitted and COVID-19 meets the definition of principal diagnosis, it should be sequenced...
by Jennifer Cayce | Dec 21, 2021 | Webinar Q&As
Q: What is the purpose of Category III codes? A: The use of category III codes allows data collection for these services/procedures. Use of unlisted codes does not offer this. If a category III code is available and describes the procedure performed, it must be...
by Shea Lunt | Dec 9, 2021 | Webinar Q&As
Q: What’s the purpose of category III codes? A: The use of category III codes allow data collection for these services/procedures. Use of unlisted codes does not offer this. If a category III code is available and describes the procedure performed, it must be...
by Kristi Pollard | Nov 22, 2021 | Webinar Q&As
Q: If an intervention is performed in the anterior tibial artery and another in the tibioperoneal trunk, can two interventions be reported? A: Yes. The tibioperoneal trunk is a continuation of the popliteal artery after the anterior tibial branches off. The TP...
by Kristi Pollard | Nov 12, 2021 | Webinar Q&As
Q: Is a chronic contained rupture considered a ruptured aneurysm? A: CPT defines rupture as an acute hemorrhage related to the aneurysm. Patients with rupture are most likely hemodynamically unstable and require emergent treatment. A chronic contained rupture or...
by Kristi Pollard | Sep 17, 2021 | Webinar Q&As
Q: VitalWare is reporting that New Technology Add-on Payment for Abecma and Tecartus but they also drive to DRG 018. How does that work? A: This is correct. CAR T-cell therapies are assigned to MS-DRG 018 through a pre-MDC. Abecma and Tecartus both also receive...
